More Articles

Patients and Medical

Tireless Campaigner Wins Recognition

Adam Chapman, (Mar 13, 2018)

Awareness advocate Trishna Bharadia takes home the prestigious Patient Advocate Award
Access and Evidence

Overcoming The Access Hurdle

Adam Chapman, (Mar 6, 2018)

If pharma is to keep whizzing ahead, it needs to rethink its approach to market access
Access and Evidence

Could EHRs Boost Clinical Trial Recruitment?

Ross Davies, (Mar 6, 2018)

Patient recruitment for clinical trials is commonly accepted to be a herculean task. A new platform could make the process a lot quicker and easier – and, crucially, not at the expense of data privacy
Patients and Medical

Navigating The Path To Value

Katie Osborne, (Feb 27, 2018)

Outcomes-based models are a progressive step for pharma, but the road to success is far from certain
Patients and Medical

Zooming In On Patient-Centricity

Adam Chapman, (Feb 22, 2018)

We train our lens on the industry's most talked up topic. How do you turn a slogan into substance?
Patients and Medical

Could Data-Driven Chat Win HCPs' Hearts?

Adam Chapman, (Feb 20, 2018)

Evidence-based interactions have the potential to forge strong new ties with one of pharma's most crucial touchpoints: the HCP

A Lesson In Leadership

Hugh Gosling, (Feb 16, 2018)

Helming an organization is a tall order, so what attributes separate the wheat from the chaff?
Access and Evidence

Raising The Curtain On Real-World Evidence

Danielle Barron, (Feb 13, 2018)

RWE continues to animate expectations far and wide, but its success calls for level-headed pragmatism
Patients and Medical

AstraZeneca: An Embarrassment Of Riches

Hugh Gosling, (Feb 7, 2018)

Medical Affairs has seen unprecedented growth in both size and scope in recent years, so new skills and capabilities are needed, says AZ’s Mark Mallon

The New Normal

Adam Chapman, (Feb 3, 2018)

The pharma industry is on the cusp of a new dawn, but what does it look like?